ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES is a peer-reviewed journal published by Mary Ann Liebert, Inc., focused on the innovative fields of pharmacology and drug development. With its ISSN 1540-658X and E-ISSN 1557-8127, the journal has successfully contributed to the scientific community since its inception in 2002, converging into one comprehensive resource by 2024. Positioned in the Q3 quartile for Drug Discovery and Q4 for Molecular Medicine as per the 2023 rankings, the journal is dedicated to disseminating cutting-edge research that addresses the complexities of drug assay techniques and their implications in therapeutics. Although currently not an open-access publication, it offers significant insights and findings valuable to researchers, professionals, and students in the realm of biochemistry and pharmacology. With a commitment to advancing knowledge and innovation, ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES continues to be an essential platform for the latest advancements in drug discovery and development.

Journal of Parasitology Research, published by HINDAWI LTD, is a pivotal open-access journal that has been disseminating groundbreaking research in the field of parasitology since 2009. With an ISSN of 2090-0023 and an E-ISSN of 2090-0031, this journal strives to provide researchers, professionals, and students with accessible and high-impact studies that advance understanding of parasitic diseases and their epidemiology. The journal currently holds a Q3 ranking in Infectious Diseases and a Q2 ranking in Parasitology, indicating its significant contribution to the academic community. Furthermore, with a Scopus ranking placing it at #39 in Parasitology and #186 in Infectious Diseases, it plays an essential role in shaping research directions in these fields. As an open-access journal, Journal of Parasitology Research enhances the visibility and accessibility of published works, ensuring crucial findings reach a global audience. With a focus on innovative research, the journal welcomes submissions that explore both theoretical frameworks and practical applications in parasitology, making it an invaluable resource for those dedicated to combating parasitic infections.

International Journal for Parasitology, published by Elsevier Sci Ltd, stands as a premier platform for disseminating groundbreaking research in the fields of parasitology and infectious diseases. With an impressive impact factor represented by its Q1 quartile rankings in both Infectious Diseases and Parasitology for 2023, this journal commands significant attention within the scientific community. Operating since 1971, it has profoundly contributed to the understanding of parasitic infections and their implications for human health, occupying a distinguished position ranked #7 out of 79 in Parasitology and #64 out of 344 in Infectious Diseases according to Scopus metrics. Although the journal currently does not offer open access options, it ensures rigorous peer review and unparalleled academic integrity, providing researchers, professionals, and students with critical insights necessary for advancing knowledge and fostering innovations in parasitology. Together with its rich historical foundation and commitment to excellence, the journal is indispensable for anyone delving into the complexities of parasites and their impact on both host and ecosystem.

Cancer Chemotherapy and Pharmacology, published by Springer, is a leading peer-reviewed journal that plays a crucial role in the field of cancer research and drug therapy. With an ISSN of 0344-5704 and an E-ISSN of 1432-0843, this journal has been a cornerstone of oncology and pharmacology research since its inception in 1978, with continued relevance through to 2024. The journal holds a commendable Q2 ranking in categories such as Cancer Research, Oncology, and Pharmacology (medical), while achieving an elite Q1 status in Toxicology, reflecting its high-impact contributions to the scientific community. Researchers and professionals benefit from access to cutting-edge studies, insightful reviews, and innovative methodologies, making it a vital resource for anyone working at the intersection of pharmacology and oncology. Although not an open-access journal, Cancer Chemotherapy and Pharmacology remains highly accessible through institutional subscriptions, ensuring it reaches a broad audience dedicated to advancing cancer treatment and patient care.

INVESTIGATIONAL NEW DRUGS is a prestigious journal published by SPRINGER, dedicated to advancing research in the fields of pharmacology and oncology. With its origins dating back to 1983, the journal continues to play a critical role in disseminating groundbreaking studies and innovative methodologies related to drug development and therapeutic strategies. It holds an impressive impact factor among leading academic publications, ranking in the top quartiles (Q1 and Q2) of its respective categories, evidenced by Scopus rankings of #43/272 in Medical Pharmacology and #88/404 in Medical Oncology. While it offers traditional subscription-based access, it remains an essential resource for researchers, professionals, and students eager to stay abreast of significant advancements in drug research. Through rigorous peer review and comprehensive coverage, INVESTIGATIONAL NEW DRUGS aims to foster the development of effective new therapies and enhance our understanding of pharmacological interventions in oncology.

Microbial Drug Resistance, published by MARY ANN LIEBERT, INC, is a pivotal journal that explores the critical intersection of microbiology and pharmacology with a keen focus on antibiotic resistance and related issues. Since its inception in 1995, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for innovative studies that inform the global response to antimicrobial resistance. With a commendable position in the Category Quartiles, ranked Q2 in Medicine (miscellaneous) and Q2 in Pharmacology for 2023, it caters to a multidisciplinary audience by addressing the implications of microbial resistance within various medical contexts. Although currently non-Open Access, the journal allows subscribers and institutions to access high-quality, peer-reviewed research, directly impacting policy and practice in healthcare settings. Committed to advancing our understanding and combating the challenges posed by resistant microbes, Microbial Drug Resistance remains an essential publication in the fields of microbiology, immunology, and pharmacology.

ANTIVIRAL THERAPY is a prominent academic journal dedicated to the field of infectious diseases and pharmacology, published by SAGE Publications Ltd in the United Kingdom. Since its inception in 1996, this journal has become an essential platform for disseminating cutting-edge research and innovative therapeutic approaches for viral infections, making significant contributions to advancements in medical science. With an HIndex indicating the quality and influence of its published work, ANTIVIRAL THERAPY holds prestigious rankings in its categories, including Q3 in Infectious Diseases and Pharmacology as of 2023. While it currently does not offer open access, the journal provides valuable insights that are crucial for researchers, healthcare professionals, and students engaged in antiviral research and treatment strategies. As it converges towards 2024, the journal continues to play a vital role in shaping the understanding and management of viral diseases, making it a critical resource for anyone involved in this important field of study.

EXPERIMENTAL PARASITOLOGY, published by Academic Press Inc Elsevier Science, is a prominent journal in the domains of immunology, infectious diseases, and parasitology, with roots extending back to 1951. This journal, bearing the ISSN 0014-4894 and E-ISSN 1090-2449, serves as a critical conduit for sharing advancements in the understanding of parasite biology, host-parasite interactions, and the immunological responses elicited by parasitic infections. Although it currently operates under a subscription model without open access options, its rigorous scholarly content is vital for researchers and practitioners alike looking to stay informed on the latest developments and applications in the field. With a recent categorization as Q3 in key scientific categories, including Infectious Diseases and Parasitology, and a Scopus ranking solidifying its relevance, EXPERIMENTAL PARASITOLOGY is an essential resource for those committed to advancing knowledge and solutions to parasitic diseases.

CURRENT DRUG TARGETS is a leading peer-reviewed journal dedicated to advancements in the fields of Clinical Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. Published by Bentham Science Publishers Ltd, this esteemed journal has solidified its position in the academic community with a 2023 Q2 ranking in several categories, highlighting its influence and relevance in drug research and development. With an ISSN of 1389-4501 and E-ISSN 1873-5592, CURRENT DRUG TARGETS facilitates the dissemination of high-quality articles that explore novel therapeutic strategies and drug design principles. Catered to researchers, professionals, and students, the journal has a commitment to advancing knowledge while addressing contemporary challenges in pharmacological sciences. As it converges from 2000 to 2024, CURRENT DRUG TARGETS remains a vital resource in understanding the complexities of drug action and interaction, making it indispensable for anyone pursuing cutting-edge research in related disciplines.

PARASITOLOGY RESEARCH, published by Springer, stands as a pivotal journal in the fields of parasitology, infectious diseases, and insect science, with a rich history dating back to 1987. Operating from Germany, this journal has garnered an impressive reputation, achieving a high ranking within various categories, including Q1 in Veterinary (miscellaneous) and Q2 across several relevant fields as of 2023. While it does not currently offer Open Access options, the journal remains a vital resource for researchers, professionals, and students seeking to contribute to and keep pace with advancements in parasitological studies. With a commitment to publishing high-quality research, PARASITOLOGY RESEARCH serves as an essential forum for disseminating findings that enhance our understanding of parasitic organisms and their impacts on health and the environment. Explore this journal to engage with cutting-edge investigations and reviews that drive innovation in parasitology and related disciplines.